Research Output per year
Fingerprint Dive into the research topics where Eugenia Marchesi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Blood Pressure
Medicine & Life Sciences
Captopril
Medicine & Life Sciences
Perindopril
Medicine & Life Sciences
LDL Lipoproteins
Medicine & Life Sciences
Hypertension
Medicine & Life Sciences
Left Ventricular Function
Medicine & Life Sciences
Multicenter Studies
Medicine & Life Sciences
Respiration
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1974 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
Palmerini, E., Jones, R. L., Setola, E., Picci, P., Marchesi, E., Luksch, R., Grignani, G., Cesari, M., Longhi, A., Abate, M. E., Paioli, A., Szucs, Z., D'ambrosio, L., Scotlandi, K., Fagioli, F., Asaftei, S. & Ferrari, S., Jul 2018, In : Acta oncologica. 57, 7, p. 958-964 7 p.Research output: Contribution to journal › Article
irinotecan
temozolomide
Ewing's Sarcoma
Pediatrics
Disease-Free Survival
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, , 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.Research output: Contribution to journal › Article
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., Jun 5 2018, In : BMC Genomics. 19, 1Research output: Contribution to journal › Article
Cholangiocarcinoma
Epithelial-Mesenchymal Transition
Genes
Cytoskeleton
Neoplasms
129
Citations
(Scopus)
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, , Jul 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.Research output: Contribution to journal › Article
Sarcoma
Multicenter Studies
Drug Therapy
Ifosfamide
Myxoid Liposarcoma
129
Citations
(Scopus)
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 8 others, , 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.Research output: Contribution to journal › Article